Research Site

Çiğli 35620

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Early Breast Cancer

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now